BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20848514)

  • 1. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
    Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
    Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients.
    Jimbo K; Ohtsuka Y; Kojima Y; Hosoi K; Ohbayashi N; Ikuse T; Aoyagi Y; Fujii T; Kudo T; Shimizu T
    Pediatr Int; 2014 Dec; 56(6):873-883. PubMed ID: 24750209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
    Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
    Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease.
    Haghbin M; Rostami-Nejad M; Forouzesh F; Sadeghi A; Rostami K; Aghamohammadi E; Asadzadeh-Aghdaei H; Masotti A; Zali MR
    Medicine (Baltimore); 2019 Jun; 98(25):e15949. PubMed ID: 31232926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.
    Bondar C; Araya RE; Guzman L; Rua EC; Chopita N; Chirdo FG
    PLoS One; 2014; 9(2):e89068. PubMed ID: 24586509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis.
    Hosomi S; Oshitani N; Kamata N; Sogawa M; Okazaki H; Tanigawa T; Yamagami H; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Maeda K; Hirakawa K; Arakawa T
    Clin Exp Immunol; 2011 Feb; 163(2):215-24. PubMed ID: 21087446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
    Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
    BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
    Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic neuritis: chemokine receptor CXCR3 and its ligands.
    Sørensen TL; Roed H; Sellebjerg F
    Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients.
    Hassanshahi F; Noroozi Karimabad M; Miranzadeh E; Hassanshahi G; Torabizadeh SA; Jebali A
    Curr Microbiol; 2023 May; 80(6):201. PubMed ID: 37140634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.